Copyright © 2016 BizPac Review, All rights reserved. You opted in to receive mail from BizPac Review
Our mailing address is:
News Alert September 10, 2016 |
|
|
|
Encouraged by a modestly-improving public market for biotechs, gene editing startup CRISPR Therapeutics disclosed plans late Friday to raise up to $90 million in an IPO. But the question remains whether CRISPR can do much better on the stock market than the other two publicly-traded gene editing companies, both of which area based in Cambridge and held IPOs earlier this year.
|
|
If you are having trouble viewing this email, click here
If you need other assistance, please let us know or contact: bizjournals.com customer service, bizjournals 120 W. Morehead St., Charlotte, North Carolina 28202
© 2016 American City Business Journals, Inc. and its licensors. All rights reserved. The material on this may not be reproduced, distributed, transmitted, cached or otherwise used, except with the written permission of bizjournals.
|
|
|
|
|
|
Nema komentara:
Objavi komentar